Mesenchymal stem/stromal cell–based therapies for COVID-19: First iteration of a living systematic review and meta-analysis
Author:
Publisher
Elsevier BV
Subject
Cancer Research,Transplantation,Cell Biology,Genetics (clinical),Oncology,Immunology,Immunology and Allergy
Reference75 articles.
1. The COVID-19 pandemic;Ciotti;Crit Rev Clin Lab Sci,2020
2. COVID-19: A New Virus, but a Familiar Receptor and Cytokine Release Syndrome;Hirano;Immunity,2020
3. How COVID-19 induces cytokine storm with high mortality;Hojyo;Inflamm Regen,2020
4. The pro-inflammatory cytokines in COVID-19 pathogenesis: What goes wrong?;Darif;Microb Pathog,2021
5. The cytokine storm and COVID-19;Hu;J Med Virol,2021
Cited by 17 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Unraveling the Complexities of Mesenchymal Stromal Cell-based Therapies: One Size Doesn’t Fit All;American Journal of Respiratory and Critical Care Medicine;2024-09-15
2. The function and effectiveness of MSCs in preclinical models of diseases;Stem Cell Transplantation [Working Title];2024-07-04
3. Potential application of mesenchymal stromal cells as a new therapeutic approach in acute respiratory distress syndrome and pulmonary fibrosis;Respiratory Research;2024-04-18
4. Update on the Use of Mesenchymal Stem Cells in the Treatment of Various Infectious Diseases Including COVID-19 Infection;Journal of Stem Cell Therapy and Transplantation;2023-12-05
5. Emerging role and therapeutic application of mesenchymal stem cell (MSC) and MSC-derived exosome in Coronavirus disease-2019 (COVID-19) infection;Recent Update on Mesenchymal Stem Cells [Working Title];2023-10-05
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3